Evidence map›Paper›PMID 38973219›Full record

ReviewAnimal models and experimental medicine2024

Developments in the study of Chinese herbal medicine's assessment index and action mechanism for diabetes mellitus.

Xin-Yue Liu, Han-Wen Zheng, Feng-Zhong Wang, Tul-Wahab Atia, Bei Fan, Qiong Wang

Abstract readReview
In one paragraph

Review in Animal models and experimental medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Fu-Fang-Qi-Di-Hua-Yu-Tang Improves Diabetic Macrovascular Disease via PI3K/AKT Pathway Regulation.Diabetes, metabolic syndrome and obesity : targets and therapy · 2025
    Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Xin-Yue LiuInstitute of Food Science and Technology, Chinese Academy of Agricultural Sciences, Beijing, China.
Han-Wen ZhengInstitute of Food Science and Technology, Chinese Academy of Agricultural Sciences, Beijing, China.
Feng-Zhong WangInstitute of Food Science and Technology, Chinese Academy of Agricultural Sciences, Beijing, China.
Tul-Wahab AtiaDr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, University of Karachi, Karachi, Pakistan.
Bei FanInstitute of Food Science and Technology, Chinese Academy of Agricultural Sciences, Beijing, China.
Qiong WangInstitute of Food Science and Technology, Chinese Academy of Agricultural Sciences, Beijing, China.

Funding

the National Key Research and Development Program of China 2021YFD1600100the National Key Research and Development Program of China 2022YFD1600303
6 · The paper itself

Abstract

In traditional Chinese medicine (TCM), based on various pathogenic symptoms and the 'golden chamber' medical text, Huangdi Neijing, diabetes mellitus falls under the category 'collateral disease'. TCM, with its wealth of experience, has been treating diabetes for over two millennia. Different antidiabetic Chinese herbal medicines reduce blood sugar, with their effective ingredients exerting unique advantages. As well as a glucose lowering effect, TCM also regulates bodily functions to prevent diabetes associated complications, with reduced side effects compared to western synthetic drugs. Chinese herbal medicine is usually composed of polysaccharides, saponins, alkaloids, flavonoids, and terpenoids. These active ingredients reduce blood sugar via various mechanism of actions that include boosting endogenous insulin secretion, enhancing insulin sensitivity and adjusting key enzyme activity and scavenging free radicals. These actions regulate glycolipid metabolism in the body, eventually achieving the goal of normalizing blood glucose. Using different animal models, a number of molecular markers are available for the detection of diabetes induction and the molecular pathology of the disease is becoming clearer. Nonetheless, there is a dearth of scientific data about the pharmacology, dose-effect relationship, and structure-activity relationship of TCM and its constituents. Further research into the efficacy, toxicity and mode of action of TCM, using different metabolic and molecular markers, is key to developing novel TCM antidiabetic formulations.

Indexed as

Diabetes MellitusDrugs, Chinese HerbalHypoglycemic AgentsAnimalsBlood GlucoseHumansMedicine, Chinese TraditionalBlood GlucoseDrugs, Chinese HerbalHypoglycemic Agentsanimal modelChinese herbal medicinediabetes mellitusevaluation indexmechanism of action

Identifiers

PMID38973219
PMCPMC11369031

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.